Literature DB >> 7133776

Prophylactic psychiatry.

C Astrup.   

Abstract

The great contributions of Gantt to the problems of prophylactic psychiatry are pointed out. The author reviews his experiences with a 30-year follow-up of a population of 1800 persons. Over the 30 years, there appeared to be a 50% increase of neuroses, which raises great problems for mental health services. The Berlevåg population was offered optimal psychiatric services. Behavior therapy of neuroses and drug treatment of depression may possibly have lowered the prevalence of mental disorders. Psychophysiologic tests were used in the project. It is hoped that such tests may be utilized for early detection and treatment of mental disorders.

Entities:  

Mesh:

Year:  1982        PMID: 7133776     DOI: 10.1007/bf03001205

Source DB:  PubMed          Journal:  Pavlov J Biol Sci        ISSN: 0093-2213


  6 in total

1.  Application of the conditional reflex method to preventive psychiatry.

Authors:  W H GANTT
Journal:  Dis Nerv Syst       Date:  1959-05

2.  Psychophysiological studies of a geographically defined population.

Authors:  H Smith-Meyer; H A Valen; K Flekkoy; K Håseth; C Astrup
Journal:  Act Nerv Super (Praha)       Date:  1976

3.  A social psychiatric investigation of a small community in northern Norway.

Authors:  J BREMER
Journal:  Acta Psychiatr Neurol Suppl       Date:  1950

4.  The Samsøo project from 1957 to 1974.

Authors:  J Nielsen
Journal:  Acta Psychiatr Scand       Date:  1976-09       Impact factor: 6.392

5.  Bimodality and lateral asymmetry of skin conductance orienting activity in schizophrenics: replication and evidence of lateral asymmetry in patients with depression and disorders of personality.

Authors:  J Gruzelier; P Venables
Journal:  Biol Psychiatry       Date:  1974-02       Impact factor: 13.382

6.  A social psychiatric investigation of a rural district in Northern Norway: a preliminary communication.

Authors:  E Bjarnar; R Melsom; H Reppesgaard; C Astrup
Journal:  Acta Psychiatr Scand       Date:  1975-01       Impact factor: 6.392

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.